LY4057996: A Study in Diabetes
We are testing a new treatment in healthy participants and those with type 1 and type 2 diabetes. The goal is to learn more about its effects and safety in these different groups.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Type 1 Diabetes
Type 1 Diabetes is a chronic condition where the pancreas produces little or no insulin, leading to high blood sugar levels. It often develops in children and young adults.
Type 2 Diabetes
Type 2 Diabetes is a long-term metabolic disorder characterized by high blood sugar, insulin resistance, and relative lack of insulin. It is more common in adults and can be managed with lifestyle changes and medication.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Eli Lilly & Co.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.